| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
961,901 | 874,119 | 643,638 | 152,985 | 67,060 |
| Cost of Revenue
|
-563,902 | -553,737 | -395,935 | -133,540 | -93,889 |
|
Gross Profit
|
397,999 | 320,382 | 247,703 | 19,445 | -26,829 |
|
Selling, General and Administrative Expenses
|
-1,713,592 | -1,912,595 | -5,573,762 | -5,814,005 | -5,290,649 |
|
Research and Development Expenses
|
-4,665,434 | -3,553,181 | -3,783,386 | -6,172,944 | -10,999,325 |
|
Operating Income/Expenses
|
-6,379,026 | -5,465,776 | -9,357,148 | -11,986,949 | -16,289,974 |
|
Total Operating Profit/Loss
|
-5,981,027 | -5,145,394 | -9,109,445 | -11,967,504 | -16,316,803 |
| Total Net Finance Income/Expense
|
-30,504 | -27,482 | -53,131 | -11,804 | -23,119 |
| Net Investment Income
|
1,944,300 | -230,425 | 1,590,161 | -165,269 | 1,315,302 |
| Irregular Income/Expenses
|
101,697 | 154,676 | -20,105,809 | -901,859 | -100,930 |
|
Other Income/Expense, Non-Operating
|
14,311 | 12,040 | 34,557 | 5,575,021 | 408,555 |
|
Non-Operating Income/Expenses, Total
|
2,029,804 | -91,191 | -18,534,222 | 4,496,089 | 1,599,808 |
|
Pretax Income
|
-3,951,219 | -5,236,583 | -27,643,667 | -7,471,415 | -14,716,994 |
| Provision for Income Tax
|
79,592 | 113,314 | -485,316 | 33,807 | 2,222 |
|
Net Income from Continuing Operations
|
-3,871,627 | -5,123,269 | -28,128,983 | -7,437,608 | -14,714,772 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-3,871,627 | -5,123,269 | -28,128,983 | -7,437,607 | -14,714,772 |
|
Net Income after Non-Controlling/Minority Interests
|
-3,871,627 | -5,123,269 | -28,128,983 | -7,437,607 | -14,714,772 |
|
Net Income Available to Common Stockholders
|
-3,871,627 | -5,123,269 | -28,128,983 | -7,437,607 | -14,714,772 |
|
Diluted Net Income Available to Common Stockholders
|
-3,871,627 | -5,123,269 | -28,128,983 | -7,437,607 | -14,714,772 |
| Basic EPS
|
-9.22 | -14.44 | -119.53 | -39.29 | -94.29 |
| Diluted EPS
|
-9.22 | -14.44 | -119.53 | -39.29 | -94.29 |
|
Basic Weighted Average Shares Outstanding
|
388,635.80 | 354,797.02 | 235,329.90 | 189,300.26 | 156,058.67 |
|
Diluted Weighted Average Shares Outstanding
|
388,635.80 | 354,797.02 | 235,329.90 | 189,300.26 | 156,058.67 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-3,946,916 | -5,251,440 | -27,648,114 | -7,479,828 | -14,718,824 |
|
EBITDA
|
-3,900,261 | -5,197,603 | -24,276,473 | -4,370,771 | -11,817,000 |
|
Normalized EBITDA
|
-6,025,423 | -5,244,231 | -5,776,554 | -3,230,749 | -13,040,405 |
|
Normalized Income
|
-3,950,431 | -5,288,775 | -7,537,856 | -5,651,225 | -14,610,015 |
|
Total Unusual Items
|
-2,125,162 | -46,628 | 18,499,919 | 1,140,022 | -1,223,405 |
|
Total Unusual Items Excluding Goodwill
|
-2,125,162 | -46,628 | 18,499,919 | 1,140,022 | -1,223,405 |
12/31/2022 - 9/25/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade